The transcription factor STAT3, which has been widely researched, is highly activated in HCC patients either directly by different cytokines and growth factors, or indirectly by the activation of the Ras/Raf/MEK/ERK pathway [5], [7], [10]. Here, MAP2K7 is linked to hepatocellular carcinoma.